|
|
Original research by the GPFC of the CHU Sainte-Justine that looked at the percentage of drug prescriptions for enteral administration requiring compounding in hospitalized children was published in Children | January 2023
|
|
|
The GPFC of the CHU Sainte-Justine has gathered important stakeholders in the pediatric community to write this commentary about the need for a regulatory framework for pediatric medications in Canada published in CMAJ Open | May 2022
|
|
|
Review article written by the GPFC of the CHU Sainte-Justine on the advances and challenges of pediatric formulations published in the BJCP | March 2022 (available upon request)
|
|
|
The GPFC of the CHU Sainte-Justine has contributed to this commentary on improving the regulations of medical cannabis to better serve Canadian children published in CMAJ Open | October 2021
|
|
|
The GPFC of the CHU Sainte-Justine participated in this important paper about the use of topical nitroglycerin in pediatrics and published in the CMAJ Open | March 2021
|
|
|
Original research by the GPFC of the CHU Sainte-Justine on pediatric formulations in Canada was published in the Canadian Journal of Hospital Pharmacy | Fall 2020
|
|
|
The GPFC of the CHU Sainte-Justine has participated in this important paper on pediatric drug data in Canadian labels of medications published in the CMAJ Open | August 2020
|
|
|
|
|
|
|
|
|
Workshop held in February 2022, organized by the GPFC of the CHU Sainte-Justine in collaboration with the Institute for Safe Medication Practices (ISMP) Canada and Children Healthcare Canada (CHC) on the challenges of compounding for parents.
|
|
|
Workshop held in February 2021, organized by the GPFC of the CHU Sainte-Justine on the Pediatric Drug Action Plan proposed by Health Canada.
|
|
|
Workshop held in February 2020, organized by the GPFC of the CHU Sainte-Justine to discuss the challenges of ensuring access to pediatric formulations in Canada.
|
|
|
Position statement on Canadian Drug Insurance and the Pediatric Perspective.
|
|
|
Position statement on improving pediatric medicines.
|
|
|
|
|
|
|
|
|
|
|
|
Presentation of the GPFC of the CHU Sainte-Justine at EuPFI annual conference, Glasgow.
|
|
|
Presentation of the GPFC of the CHU Sainte-Justine at the side event of the 76th World Health Assembly (WHA).
|
|
|
Presentation of the GPFC of the CHU Sainte-Justine at the Canadian Association for Health Services and Policy Research (CAHSPR) annual conference.
|
|
|
Presentation of the GPFC of the CHU Sainte-Justine at the Canadian Society of Pharmacology and Therapeutics (CSPT) annual conference.
|
|
|
Poster presented by the GPFC of the CHU Sainte-Justine at the Canadian Society of Hospital Pharmacists (CSPH) annual conference.
|
|
|
Presentation by the GPFC of the CHU Sainte-Justine at the Canadian DIA annual meeting.
|
|
|
Poster presented by the GPFC of the CHU Sainte-Justine at the Paediatric Academic Societies annual conference.
|
|
|
"Increasing Access to Safe and
Effective Pediatric Formulations".
|
|
|
"Age-Appropriate Formulations at Any Cost? A Canadian Case Example".
|
|
|
"An Urgent Need for Canada to Have Access to Commercial Pediatric Formulations: Children Deserve the Same Standards as Adults".
|
|
|
"Advancing Pediatric Formulations".
|
|
|
"Considerations for the Pediatric
Formulations of Cannabis".
|
|
|
"The Goodman Pediatric Formulations Centre".
|
|
|
"A Pan-Canadian Study On The Compounded Medicines Most In Need Of Commercialized Oral Pediatric Formulations".
|
|
|
Medication Safety Initiative | September 2021.
|